| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.074 | 0.2 |